These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 25485378)
1. A method for predicting the outcomes of combined pharmacologic and deep brain stimulation therapy for Parkinson's disease. Shamir RR; Dolbert T; Noecker AM; Frankemolle AM; Walter BL; McIntyre CC Med Image Comput Comput Assist Interv; 2014; 17(Pt 2):188-95. PubMed ID: 25485378 [TBL] [Abstract][Full Text] [Related]
2. Machine Learning Approach to Optimizing Combined Stimulation and Medication Therapies for Parkinson's Disease. Shamir RR; Dolber T; Noecker AM; Walter BL; McIntyre CC Brain Stimul; 2015; 8(6):1025-32. PubMed ID: 26140956 [TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease. Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947 [TBL] [Abstract][Full Text] [Related]
4. Varying time-course of effects of high frequency stimulation of sub-regions of the globus pallidus in patients with parkinson's disease. Angeli A; Akram H; Zacharia A; Limousin P; Hariz M; Zrinzo L; Foltynie T Parkinsonism Relat Disord; 2015 Jun; 21(6):597-602. PubMed ID: 25842261 [TBL] [Abstract][Full Text] [Related]
5. A model-based approach for assessing parkinsonian gait and effects of levodopa and deep brain stimulation. Cho C; Osaki Y; Kunin M; Cohen B; Olanow CW; Raphan T Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():1228-31. PubMed ID: 17946882 [TBL] [Abstract][Full Text] [Related]
6. Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation. Wider C; Russmann H; Villemure JG; Robert B; Bogousslavsky J; Burkhard PR; Vingerhoets FJ Arch Neurol; 2006 Jul; 63(7):951-5. PubMed ID: 16831963 [TBL] [Abstract][Full Text] [Related]
7. Protocol of a randomized open label multicentre trial comparing continuous intrajejunal levodopa infusion with deep brain stimulation in Parkinson's disease - the INfusion VErsus STimulation (INVEST) study. van Poppelen D; Sisodia V; de Haan RJ; Dijkgraaf MGW; Schuurman PR; Geurtsen GJ; Berk AEM; de Bie RMA; Dijk JM BMC Neurol; 2020 Jan; 20(1):40. PubMed ID: 32005175 [TBL] [Abstract][Full Text] [Related]
8. Fusion image-based programming after subthalamic nucleus deep brain stimulation. Paek SH; Kim HJ; Yoon JY; Heo JH; Kim C; Kim MR; Lim YH; Kim KR; Kim JW; Han JH; Kim DG; Jeon BS World Neurosurg; 2011; 75(3-4):517-24. PubMed ID: 21600506 [TBL] [Abstract][Full Text] [Related]
9. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa. Lyons KE; Davis JT; Pahwa R Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749 [TBL] [Abstract][Full Text] [Related]
10. Effects of deep brain stimulation and medication on strength, bradykinesia, and electromyographic patterns of the ankle joint in Parkinson's disease. Vaillancourt DE; Prodoehl J; Sturman MM; Bakay RA; Metman LV; Corcos DM Mov Disord; 2006 Jan; 21(1):50-8. PubMed ID: 16124011 [TBL] [Abstract][Full Text] [Related]
11. Duodenal Levodopa Infusion for Long-Term Deep Brain Stimulation-Refractory Symptoms in Advanced Parkinson Disease. Regidor I; Benita V; Del Álamo de Pedro M; Ley L; Martinez Castrillo JC Clin Neuropharmacol; 2017; 40(3):103-107. PubMed ID: 28452905 [TBL] [Abstract][Full Text] [Related]
13. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients. Tir M; Devos D; Blond S; Touzet G; Reyns N; Duhamel A; Cottencin O; Dujardin K; Cassim F; Destée A; Defebvre L; Krystkowiak P Neurosurgery; 2007 Aug; 61(2):297-304; discussion 304-5. PubMed ID: 17762742 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects. Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833 [TBL] [Abstract][Full Text] [Related]
15. Jejunal levodopa infusion in long-term DBS patients with Parkinson's disease. Klostermann F; Jugel C; Marzinzik F Mov Disord; 2011 Oct; 26(12):2298-9. PubMed ID: 21714008 [No Abstract] [Full Text] [Related]
16. Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease. Kim JH; Chang WS; Jung HH; Chang JW Yonsei Med J; 2015 Sep; 56(5):1316-21. PubMed ID: 26256974 [TBL] [Abstract][Full Text] [Related]
17. Deep Brain Stimulation for Parkinson Disease in the Philippines: Outcomes of the Philippine Movement Disorder Surgery Center. Diestro JDB; Vesagas TS; Teleg RA; Aguilar JA; Anlacan JP; Jamora RDG World Neurosurg; 2018 Jul; 115():e650-e658. PubMed ID: 29709756 [TBL] [Abstract][Full Text] [Related]